Last reviewed · How we verify

Blood laboratory tests

NYU Langone Health · FDA-approved active Biologic ✓ Verified May 2026 Quality 5/100

Blood laboratory tests is a Biologic drug developed by NYU Langone Health. It is currently FDA-approved.

Blood laboratory tests are used to diagnose and monitor conditions such as pneumonia, viral infection, and malaria, as well as to study the effectiveness of treatments like insulin therapy and immunotherapies. These tests involve analyzing whole blood, which is a mixture of blood cells and plasma, to identify biomarkers and understand disease progression.

At a glance

Generic nameBlood laboratory tests
SponsorNYU Langone Health
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Blood laboratory tests

What is Blood laboratory tests?

Blood laboratory tests is a Biologic drug developed by NYU Langone Health.

Who makes Blood laboratory tests?

Blood laboratory tests is developed and marketed by NYU Langone Health (see full NYU Langone Health pipeline at /company/nyu-langone-health).

What development phase is Blood laboratory tests in?

Blood laboratory tests is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing